Celltech acquisition sends mixed messages.
Mitchell
Peter
P
D061067:Antibodies, Monoclonal, Humanized; D001530:Belgium; D001709:Biotechnology / Q000191:economics*; D000068582:Certolizumab Pegol; D004345:Drug Industry / Q000191:economics*; D007140:Immunoglobulin Fab Fragments; D011092:Polyethylene Glycols / Q000191:economics; D006113:United Kingdom
D061067:Antibodies, Monoclonal, Humanized; D007140:Immunoglobulin Fab Fragments; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol